Your browser doesn't support javascript.
loading
Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysis.
Thiele, T; Alt-Mayer, T; Greinacher, A; Bux, J.
Affiliation
  • Thiele T; Institute for Immunology and Transfusion Medicine, Universitätsmedizin Greifswald, Greifswald, Germany.
  • Alt-Mayer T; German Red Cross Blood Service West, Bad Kreuznach, Germany.
  • Greinacher A; Institute for Immunology and Transfusion Medicine, Universitätsmedizin Greifswald, Greifswald, Germany.
  • Bux J; Ruhr University, Bochum, Germany.
Vox Sang ; 111(4): 350-356, 2016 Nov.
Article in En | MEDLINE | ID: mdl-27432635
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Plateletpheresis / Blood Safety Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Plateletpheresis / Blood Safety Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Year: 2016 Type: Article